FDA inspection
BioLyte Laboratories, LLC: FDA inspection ending Apr 27, 2023
FDA inspection 1205037 · Official Action Indicated (OAI) · Grand Rapids, MI
Key facts
| Inspection ID | 1205037 |
|---|---|
| Firm | BioLyte Laboratories, LLC |
| FEI number | 3013171766 |
| Address | 310 Northern Dr Nw |
| City | Grand Rapids |
| State | MI |
| ZIP | 49534 |
| Country | United States |
| Fiscal year | 2023 |
| Inspection end date | Apr 27, 2023 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data